UK Markets open in 7 hrs 36 mins

Lonza Group Ltd (0QNO.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
754.94+8.14 (+1.09%)
At close: 6:52PM BST
Full screen
Previous close746.80
Open756.40
Bid0.00 x N/A
Ask0.00 x N/A
Day's range750.80 - 757.80
52-week range750.80 - 757.80
Volume14,806
Avg. volumeN/A
Market cap55.864B
Beta (5Y monthly)0.41
PE ratio (TTM)64.91
EPS (TTM)11.63
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Capital Markets Day 2021: Lonza to Capture Market Demand and Ensure Sustainable Value Creation Through Long-Term Growth

    Lonza Group AG / Key word(s): Conference/Forecast12-Oct-2021 / 07:01 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad Hoc News Release Pursuant to Art. 53 Listing Rules At its Capital Markets Day, Lonza outlined strategic priorities and innovation highlights with a clear focus on sustainable value creation Accelerated, de-risked, long-term investment program will drive sustainable business growth 2021 CAPEX a

  • Reuters

    Vaccine business helps Lonza lift 2021 sales outlook

    ZURICH (Reuters) -Swiss contract drugmaker Lonza raised its 2021 outlook on Friday after booming business making ingredients for COVID-19 vaccines and strong growth elsewhere helped it beat analysts' expectations during the first half of the year. "In the prior year we provided an estimate for how much we expected from Moderna sales for 2021...the number is much higher given our ability to increase output at our existing facilities," Chief Financial Officer Rodolfo Savitzky told reporters. Its previous guidance had been for sales growth in the low double-digit range.